Kelly Shi
Stock Analyst at Jefferies
(2.89)
# 1,517
Out of 5,143 analysts
34
Total ratings
45.45%
Success rate
10.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $6.92 | +30.06% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $70.74 | +72.46% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $75.56 | +1.91% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $156.32 | -5.32% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $39.90 | -29.82% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $16.85 | +161.13% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.36 | +135.85% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $7.08 | +634.46% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $6.08 | +130.26% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $23.23 | -18.21% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $216.66 | -9.54% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $4.75 | +342.11% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $20.52 | +80.31% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.15 | +179.07% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $104.67 | -22.61% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.88 | +52.97% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.34 | +1,438.46% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $16.71 | -4.25% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $24.23 | -17.46% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $8.07 | +5,253.16% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $15.81 | +228.91% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.50 | +980.00% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.69 | +1,852.66% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.92
Upside: +30.06%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $70.74
Upside: +72.46%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $75.56
Upside: +1.91%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $156.32
Upside: -5.32%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $39.90
Upside: -29.82%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $16.85
Upside: +161.13%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.36
Upside: +135.85%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $7.08
Upside: +634.46%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $6.08
Upside: +130.26%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $23.23
Upside: -18.21%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $216.66
Upside: -9.54%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $4.75
Upside: +342.11%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $20.52
Upside: +80.31%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.15
Upside: +179.07%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $104.67
Upside: -22.61%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $22.88
Upside: +52.97%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.34
Upside: +1,438.46%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $16.71
Upside: -4.25%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $24.23
Upside: -17.46%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $8.07
Upside: +5,253.16%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $15.81
Upside: +228.91%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.50
Upside: +980.00%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.69
Upside: +1,852.66%